Estrogen Diastolic Heart Failure

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Menopause

In brief

Peri-menopausal women will be randomized to hormone replacement therapy or placebo for 12 weeks to determine if markers of systolic and diastolic function change by echocardiography as well as laboratory markers of heart failure, including b-type natriuretic peptide (BNP).

Key facts

Study ID
NCT02693002
Run by
Gretchen Wells
People needed
4
Starts
2016-02-01
Expected to finish
2016-11-01
Last updated by the study team
2018-08-08

Who can join

Age: 45 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.